{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:49:45Z","timestamp":1760852985554},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.neulet.2004.03.009","type":"journal-article","created":{"date-parts":[[2004,5,8]],"date-time":"2004-05-08T07:37:11Z","timestamp":1084001831000},"page":"11-13","source":"Crossref","is-referenced-by-count":2,"title":["Chronic administration of 2-(2-benzofuranyl)-2-imidazoline (2-BFI) induces region-specific increases in [3H]2-BFI binding to rat central imidazoline I2 sites"],"prefix":"10.1016","volume":"363","author":[{"given":"Nicholas","family":"MacInnes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila L.","family":"Handley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2004.03.009_BIB1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/PL00005026","article-title":"Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterisation, regulation and relation to monoamine oxidase enzymes","volume":"356","author":"Alemany","year":"1997","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.neulet.2004.03.009_BIB2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1476-5381.1995.tb13280.x","article-title":"The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors","volume":"114","author":"Alemany","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neulet.2004.03.009_BIB3","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/j.1476-5381.1996.tb15640.x","article-title":"Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non-adrenoceptor [3H]-idazoxan binding sites","volume":"118","author":"Escriba","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neulet.2004.03.009_BIB4","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1476-5381.1991.tb12416.x","article-title":"The effects of idazoxan and other \u03b12-adrenoceptor antagonists on food and water intake in the rat","volume":"104","author":"Jackson","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neulet.2004.03.009_BIB5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0014-2999(98)00389-6","article-title":"Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in the rat brain: a selective ligand for imidazoline I2 receptors","volume":"353","author":"Lione","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2004.03.009_BIB6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0014-2999(01)01259-6","article-title":"Region-dependent effects of acute and chronic tranylcypromine in vivo on [3H]2-BFI binding to brain imidazoline I2 sites","volume":"428","author":"MacInnes","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2004.03.009_BIB7","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/sj.bjp.0704579","article-title":"Characterisation of the discriminable stimulus produced by 2-BFI: effects of imidazoline I2-site ligands, MAOIs, \u03b2-carbolines, agmatine and ibogaine","volume":"135","author":"MacInnes","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neulet.2004.03.009_BIB8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0091-3057(03)00136-9","article-title":"Discriminative stimulus effects of 2-BFI: evidence of 5-HT and selective noradrenergic receptor activation","volume":"75","author":"MacInnes","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neulet.2004.03.009_BIB9","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1111\/j.1476-5381.1995.tb16655.x","article-title":"[3H]-RS-45041-190: a selective high-affinity radioligand for I2 imidazoline receptors","volume":"116","author":"MacKinnon","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neulet.2004.03.009_BIB10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1995.tb32397.x","article-title":"Functional studies of specific imidazoline-2 receptor ligands","volume":"763","author":"Nutt","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neulet.2004.03.009_BIB11","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1476-5381.1994.tb14842.x","article-title":"The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain","volume":"111","author":"Olmos","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neulet.2004.03.009_BIB12","first-page":"A63","article-title":"The irreversible I-2 ligand BU99006 abolishes [3H]2BFI binding without effect on monoamine oxidase activity","volume":"16","author":"Paterson","year":"2002","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neulet.2004.03.009_BIB13","series-title":"The Rat Brain in Stereotaxic Co-ordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.neulet.2004.03.009_BIB14","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1124\/mol.58.5.1085","article-title":"Analysis of the pharmacological and molecular heterogeneity of I2-imidazoline-binding proteins using monoamine oxidase-deficient mouse models","volume":"58","author":"Remaury","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neulet.2004.03.009_BIB15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/sj.bjp.0703294","article-title":"Activation of I2-imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors","volume":"130","author":"S\u00e1nchez-Bl\u00e1zquez","year":"2000","journal-title":"Br. J. Pharmacol."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394004002873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394004002873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T11:27:20Z","timestamp":1549711640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394004002873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0304394004002873"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2004.03.009","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}